- Report
- August 2024
- 175 Pages
Global
From €4753EUR$5,000USD£3,993GBP
- Clinical Trials
- April 2024
- 80 Pages
Global
From €1901EUR$2,000USD£1,597GBP
- Report
- August 2024
- 178 Pages
Global
From €2377EUR$2,500USD£1,997GBP
- Drug Pipelines
- August 2024
- 150 Pages
Global
From €2651EUR$2,789USD£2,227GBP
- Report
- June 2024
- 200 Pages
Global
From €7558EUR$7,950USD£6,349GBP
- Report
- January 2022
- 60 Pages
Global
From €3755EUR$3,950USD£3,155GBP
- Report
- May 2023
- 160 Pages
Global
From €4705EUR$4,949USD£3,952GBP
- Report
- April 2023
- 115 Pages
Global
From €4516EUR$4,750USD£3,794GBP
- Report
- November 2023
- 182 Pages
Global
From €4278EUR$4,500USD£3,594GBP
- Report
- August 2022
United States
From €1844EUR$1,940USD£1,549GBP
- Report
- August 2022
Global
From €751EUR$790USD£631GBP
- Drug Pipelines
- September 2020
- 120 Pages
Global
From €1901EUR$2,000USD£1,597GBP
- Report
- July 2023
- 220 Pages
Global
€4368EUR$4,595USD£3,670GBP
- Report
- June 2022
- 111 Pages
Global
From €1901EUR$2,000USD£1,597GBP

Sinusitis is a common condition that affects the sinuses, which are the air-filled cavities in the skull. It is caused by inflammation of the sinuses due to infection, allergies, or other irritants. Treatment for sinusitis typically involves antibiotics, decongestants, and antihistamines.
The sinusitis drug market is a subset of the larger respiratory drug market. It includes medications used to treat sinusitis, such as antibiotics, decongestants, and antihistamines. These drugs are used to reduce inflammation, reduce mucus production, and reduce the severity of symptoms. In addition, some drugs are used to prevent sinusitis from recurring.
The sinusitis drug market is highly competitive, with many companies offering a variety of products. Some of the major players in the market include Pfizer, GlaxoSmithKline, Merck, Sanofi, and Novartis. Other companies include AstraZeneca, Teva Pharmaceuticals, and Mylan. Show Less Read more